Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
100%
Carcinoma
Medicine & Life Sciences
73%
Ovarian Neoplasms
Medicine & Life Sciences
71%
Carcinoma in Situ
Medicine & Life Sciences
63%
Neoplasms
Medicine & Life Sciences
48%
Cytomegalovirus
Medicine & Life Sciences
37%
osimertinib
Medicine & Life Sciences
29%
Colorectal Neoplasms
Medicine & Life Sciences
29%
Chen, C. M. ,
Chen, S. M. ,
Lin, S. F. ,
Liang, H. C. &
Wu, C. C. ,
8月 2021 ,
於: Polymers. 13 ,
15 , 2552.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Polycaprolactone
100%
Calcium
71%
Bone
63%
Compression Strength
46%
Defects
44%
Huang, W. C. ,
Yadav, V. K. ,
Cheng, W. H. ,
Wang, C. H. ,
Hsieh, M. S. ,
Huang, T. Y. ,
Lin, S. F. ,
Yeh, C. T. &
Kuo, K. T. ,
12月 1 2021 ,
於: Cancers. 13 ,
23 , 6005.
研究成果: 雜誌貢獻 › 文章 › 同行評審
osimertinib
100%
Cancer-Associated Fibroblasts
56%
Non-Small Cell Lung Carcinoma
56%
Mitogen-Activated Protein Kinase Kinases
39%
trametinib
35%
Asaka, S. ,
Davis, C. ,
Lin, S. F. ,
Wang, T. L. ,
Heaphy, C. M. &
Shih, I. M. ,
8月 1 2019 ,
於: American Journal of Surgical Pathology. 43 ,
8 ,
p. 1083-1091 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carcinoma in Situ
100%
Telomere
96%
Ovarian Neoplasms
80%
Carcinoma
58%
Telomere Shortening
43%
Wu, R. C. ,
Wang, P. ,
Lin, S. F. ,
Zhang, M. ,
Song, Q. ,
Chu, T. ,
Wang, B. G. ,
Kurman, R. J. ,
Vang, R. ,
Kinzler, K. ,
Tomasetti, C. ,
Jiao, Y. ,
Shih, I. M. &
Wang, T. L. ,
5月 2019 ,
於: Journal of Pathology. 248 ,
1 ,
p. 41-50 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ovarian Neoplasms
100%
Carcinoma in Situ
93%
Carcinoma
72%
Mutation
23%
History
20%
Pisanic, T. R. ,
Asaka, S. ,
Lin, S. F. ,
Yen, T. T. ,
Sun, H. ,
Bahadirli-Talbott, A. ,
Wang, T. H. ,
Burns, K. H. ,
Wang, T. L. &
Shih, I. M. ,
3月 2019 ,
於: American Journal of Pathology. 189 ,
3 ,
p. 513-520 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Retroelements
100%
Carcinoma in Situ
72%
Ovarian Neoplasms
69%
Carcinoma
50%
Fallopian Tubes
30%